Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Kongmalai T, Looareesuwan P, Tansawet A, Siriyotha S, Kunakorntham P, Boonwatcharapai B, Attia J, McKay GJ, Thakkinstian A
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.